We are live on ! Find out more
MIM

Monashee Investment Management Portfolio holdings

AUM $184M
1-Year Est. Return 197.43%
This Fund
S&P 500
This Quarter Est. Return
+2.5%
1 Year Est. Return
+197.43%
3 Year Est. Return
+447.04%
5 Year Est. Return
+479.31%
10 Year Est. Return
+5,610.42%
AUM
$405M
AUM Growth
-$137M
Cap. Flow
-$131M
Cap. Flow %
-32.46%
Top 10 Hldgs %
79.23%
Holding
289
New
27
Increased
4
Reduced
8
Closed
245

Sector Composition

Rank Sector Weight
1 Healthcare 24.5%
2 Financials 4.73%
3 Real Estate 2.66%
4 Materials 1.45%
5 Consumer Staples 1.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LOCL icon
26
Local Bounti
LOCL
$23.5M
$2.58M 0.64%
+30,769
New +$3.41M
SI
27
DELISTED
Silvergate Capital Corporation
SI
$2.37M 0.59%
+16,000
New +$2.74M
SRZN icon
28
Surrozen
SRZN
$301M
$2.25M 0.56%
23,333
-10,000
-30% -$1.13M
HCP
29
DELISTED
HashiCorp, Inc. Class A Common Stock
HCP
$2.07M 0.51%
+22,750
New +$1.98M
BLU
30
DELISTED
BELLUS Health Inc.
BLU
$2.01M 0.5%
+250,000
New +$1.66M
NU icon
31
Nu Holdings
NU
$66.9B
$1.88M 0.46%
+200,000
New +$1.96M
STWD icon
32
Starwood Property Trust
STWD
$6.09B
$1.82M 0.45%
+75,000
New +$1.89M
KDNY
33
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$1.55M 0.38%
+95,000
New +$1.35M
SBDS
34
DELISTED
Solo Brands Inc
SBDS
$1.41M 0.35%
+2,250
New +$1.55M
LEGN icon
35
Legend Biotech
LEGN
$4.01B
$1.4M 0.35%
+30,000
New +$1.52M
THRN
36
DELISTED
Thorne Healthtech, Inc. Common Stock
THRN
$1.31M 0.32%
211,250
-145,000
-41% -$1.13M
DYN icon
37
Dyne Therapeutics
DYN
$4.9B
$1.13M 0.28%
+95,300
New +$1.34M
BTTX
38
DELISTED
Better Therapeutics, Inc. Common Stock
BTTX
$1.01M 0.25%
+217,900
New +$1.79M
IOT icon
39
Samsara
IOT
$23.8B
$843K 0.21%
+30,000
New +$781K
FREEW
40
DELISTED
Whole Earth Brands, Inc. Warrant
FREEW
$657K 0.16%
561,440
-20,966
-4% -$30K
VRAY
41
DELISTED
ViewRay, Inc.
VRAY
$551K 0.14%
+100,000
New +$609K
PERI icon
42
Perion Network
PERI
$386M
$481K 0.12%
+20,000
New +$488K
AFTR.WS
43
DELISTED
AfterNext HealthTech Acquisition Corp Warrants
AFTR.WS
$47K 0.01%
+66,664
New +$54.6K
UPH.WS
44
DELISTED
UpHealth, Inc. Warrants exercisable for one share of Common Stock at an exercise price of $115.00 per share
UPH.WS
$14K ﹤0.01%
49,997
ABLLW
45
DELISTED
Abacus Life Warrant
ABLLW
-249,999
Closed -$160K
ACHR icon
46
Archer Aviation
ACHR
$4.26B
-200,000
Closed -$1.78M
ACT icon
47
Enact Holdings
ACT
$6.73B
-50,000
Closed -$1.1M
AGL icon
48
Agilon Health
AGL
$1.6B
-3,800
Closed -$2.49M
AKA icon
49
a.k.a. Brands
AKA
$119M
-13,750
Closed -$1.41M
AMBP.WS
50
DELISTED
Ardagh Metal Packaging Warrants
AMBP.WS
-59,998
Closed -$129K

Similar funds

Monashee Investment Management's Q4 2021 Portfolio in Review

As of Q4 2021, Monashee Investment Management held 289 positions worth $405M, down 25% from $542M the previous quarter. Its ten largest holdings account for 79% of the portfolio.

Monashee Investment Management withdrew a net $131M in Q4 2021, closing 245 positions and reducing 8 holdings. Its most notable exit was Maravai LifeSciences, an estimated $9.08M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 27% a quarter earlier, followed by Financials and Real Estate.

Against the trend, Monashee Investment Management opened a new position in Hyperfine worth $15.7M.

  • Monashee Investment Management's largest Q4 2021 buy was Hyperfine: 2,171,395 shares worth $15.7M.
  • Monashee Investment Management added most to Vanguard Morningstar Total Stock Market ETF in Q4 2021, an estimated $55.6M increase.
  • Monashee Investment Management's biggest Q4 2021 reduction was SomaLogic, Inc. Class A Common Stock, cutting an estimated $7.86M.
  • Monashee Investment Management fully exited Maravai LifeSciences in Q4 2021, selling an estimated $9.08M.
  • Monashee Investment Management's ten largest holdings make up 79% of its $405M portfolio in Q4 2021.
  • Monashee Investment Management opened 27 new positions and closed 245 in Q4 2021.
  • Monashee Investment Management's portfolio value fell 25% quarter-over-quarter to $405M.

Based on Monashee Investment Management's 13F filing for Q4 2021, filed 7 Feb 2022.